These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1755019)

  • 1. Dehydration is the first step in the bioactivation of haloperidol to its pyridinium metabolite.
    Fang J; Gorrod JW
    Toxicol Lett; 1991 Dec; 59(1-3):117-23. PubMed ID: 1755019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an N-methyl-4-phenylpyridinium-like metabolite of the antidiarrheal agent loperamide in human liver microsomes: underlying reason(s) for the lack of neurotoxicity despite the bioactivation event.
    Kalgutkar AS; Nguyen HT
    Drug Metab Dispos; 2004 Sep; 32(9):943-52. PubMed ID: 15319335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic studies on haloperidol and its tetrahydropyridine analog in C57BL/6 mice.
    Van der Schyf CJ; Castagnoli K; Usuki E; Fouda HG; Rimoldi JM; Castagnoli N
    Chem Res Toxicol; 1994; 7(3):281-5. PubMed ID: 8075357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite.
    Subramanyam B; Woolf T; Castagnoli N
    Chem Res Toxicol; 1991; 4(1):123-8. PubMed ID: 1912294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the conversion of haloperidol and its tetrahydropyridine dehydration product to potentially neurotoxic pyridinium metabolites by human liver microsomes.
    Usuki E; Pearce R; Parkinson A; Castagnol N
    Chem Res Toxicol; 1996 Jun; 9(4):800-6. PubMed ID: 8831826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxin N-methyl-4-phenylpyridinium (MPP+) towards cultured dopaminergic neuroblastoma cells.
    Fang J; Zuo D; Yu PH
    Psychopharmacology (Berl); 1995 Oct; 121(3):373-8. PubMed ID: 8584620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the metabolism of haloperidol.
    Gorrod JW; Fang J
    Xenobiotica; 1993 May; 23(5):495-508. PubMed ID: 8342297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse liver preparations.
    Baker JK; Borne RF; Davis WM; Waters IW
    Biochem Biophys Res Commun; 1984 Dec; 125(2):484-90. PubMed ID: 6335033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated beta-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6.
    Herraiz T; Guillén H; Arán VJ; Idle JR; Gonzalez FJ
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):387-98. PubMed ID: 16870220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of a neurotoxic quaternary pyridinium metabolite in the liver of haloperidol-treated rats.
    Ablordeppey SY; Borne RF
    Pharmacol Biochem Behav; 1993 Nov; 46(3):739-44. PubMed ID: 8278454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyltetrahydro-beta-carboline analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin are oxidized to neurotoxic beta-carbolinium cations by heme peroxidases.
    Herraiz T; Guillén H; Galisteo J
    Biochem Biophys Res Commun; 2007 Apr; 356(1):118-23. PubMed ID: 17346675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by liver homogenate fractions.
    Weissman J; Trevor A; Chiba K; Peterson LA; Caldera P; Castagnoli N; Baillie T
    J Med Chem; 1985 Aug; 28(8):997-1001. PubMed ID: 3874963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic aspects of the behavior of MPTP and some analogues.
    Tipton KF; McCrodden JM; Sullivan JP
    Adv Neurol; 1993; 60():186-93. PubMed ID: 8420134
    [No Abstract]   [Full Text] [Related]  

  • 14. 1-Methyl-4-phenyl-pyridinium-induced inhibition of nicotinamide adenosine dinucleotide cytochrome c reductase.
    Poirier J; Barbeau A
    Neurosci Lett; 1985 Nov; 62(1):7-11. PubMed ID: 3877888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Singer TP; Castagnoli N; Ramsay RR; Trevor AJ
    J Neurochem; 1987 Jul; 49(1):1-8. PubMed ID: 3495634
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidol.
    Subramanyam B; Pond SM; Eyles DW; Whiteford HA; Fouda HG; Castagnoli N
    Biochem Biophys Res Commun; 1991 Dec; 181(2):573-8. PubMed ID: 1755839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra.
    Langston JW; Irwin I; Langston EB; Forno LS
    Neurosci Lett; 1984 Jul; 48(1):87-92. PubMed ID: 6332288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes.
    Di Monte DA; Wu EY; Irwin I; Delanney LE; Langston JW
    J Pharmacol Exp Ther; 1991 Aug; 258(2):594-600. PubMed ID: 1907660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and the N-methyl-4-phenylpyridinium ion (MPP+) into fetal mouse brain through the placenta.
    Ohya Y; Naoi M; Ochi N; Mizutani N; Watanabe K; Nagatsu T
    Neurosci Lett; 1989 Oct; 105(1-2):221-6. PubMed ID: 2485882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic method for the detection and quantitation of haloperidol and seven of its metabolites in microsomal preparations.
    Fang J; Gorrod JW
    J Chromatogr; 1993 May; 614(2):267-73. PubMed ID: 8314939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.